
Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.
Source link
Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.
Source link
Administrator
Welcome to Untold Theory, where innovation meets insight. We are dedicated to uncovering the hidden dimensions of technology, science, and the digital world. Our mission is to deliver 100% accurate content that keeps you ahead of the curve.we bring you the latest trends, deep dives into emerging technologies, and thought-provoking analyses—all designed to fuel your curiosity. Untold Theory is your go-to source for exploring the untold stories behind the world's most transformative ideas.Join us on this journey of discovery, where every article sheds light on the theories shaping our future.